Vega Investment Solutions’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$486K Buy
6,939
+345
+5% +$17.9K 0.07% 80
2026
Q1
$335K Sell
6,594
-211
-3% -$9.84K 0.08% 66
2025
Q4
$201K Buy
+6,805
New +$185K 0.03% 79
2025
Q2
$105K Sell
3,822
-258
-6% -$6.79K 0.02% 73
2025
Q1
$116K Buy
4,080
+3,000
+278% +$106K 0.02% 102
2024
Q4
$44.9K Buy
+1,080
New +$51.6K 0.04% 65

Other funds holding MRNA

Vega Investment Solutions's MRNA Position: Q2 2026 in Review

Vega Investment Solutions increased its Moderna (MRNA) stake by 5.2% in Q2 2026, buying an estimated $17.9K and bringing the position to 6,939 shares worth $486K. The position accounts for 0.07% of the portfolio, ranked #80.

Vega Investment Solutions first reported a position in MRNA in Q4 2024 and has held it in 6 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Vega Investment Solutions held 6,939 shares of Moderna worth $486K as of Q2 2026.
  • Vega Investment Solutions bought 345 Moderna shares in Q2 2026, an estimated $17.9K.
  • Moderna made up 0.07% of Vega Investment Solutions's portfolio in Q2 2026, its #80 holding.
  • Vega Investment Solutions first reported a position in Moderna in Q4 2024 and has held it in 6 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Vega Investment Solutions's 13F filing for Q2 2026, filed 13 Aug 2026.